5 Result(s)
within
Kriengsak Vareesangthip
-
Article
Open AccessEconomic evaluation of peritoneal dialysis and hemodialysis in Thai population with End-stage Kidney Disease
This study aimed to conduct a cost-utility analysis of the “Peritoneal Dialysis (PD)-First” policy in 2008 under a universal health coverage scheme and hemodialysis (HD) in Thai patients with End-stage Kidney ...
-
Article
Open AccessCost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand
Chronic kidney disease (CKD) creates a significant economic burden on patients and society. The DAPA-CKD trial reports the benefit of dapagliflozin in CKD patients; however, its cost-effectiveness is unknown i...
-
Article
Open AccessCost–Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand
Diabetes treatment has incurred financial burden. We examined the cost–utility of adding dapagliflozin to the standard treatment for treating type 2 diabetes (T2DM) with cardiovascular risk in a Thai context.
-
Article
Open AccessPrevalence of chronic kidney disease in Thai adults: a national health survey
The prevalence of patients with end stage renal disease (ESRD) who need dialysis and/or transplantation has more than doubled in Thailand during the past two decades. It has been suggested that therapeutic str...
-
Article
Open AccessNovel and de novo PKD1 mutations identified by multiple restriction fragment-single strand conformation polymorphism (MRF-SSCP)
We have previously developed a long RT-PCR method for selective amplification of full-length PKD1 transcripts (13.6 kb) and a long-range PCR for amplification in the reiterated region (18 kb) covering exons 14 an...
